BridgeBio Pharma (BBIO) Fair Value & DCF

BBIO$76.52-0.84 -1.09%
BiotechnologyLarge CapGrowth Stock
Compare
Market cap$14.91BEnterprise value$16.13BRevenue (TTM)$945.54MMarket positionTop 25%

Score

56
Neutral
Value
39
Quality
30
Growth
98

BridgeBio Pharma, Inc. (BBIO) trades at $76.52 on $14.91B of equity value, with a trailing P/E of -25.62. Fair value on Stocklytics blends discounted cash flow and an earnings-based cross-check when the saved model is on file. The price and ratio here are from the live quote.

BridgeBio Pharma (BBIO) Fair Value & DCF

BBIO price $76.52 -0.84 -1.09%

Ticker
BBIO
Price
$76.52
Change
-0.84 -1.09%
Market cap
$14.91B
Forward P/E
43.17
Dividend yield
0.00%
Beta
0.97
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
56
Value
39
Quality
30
Growth
98

Stocklytics score rationale: value 39, quality 30, growth 98.

AI Score 30. BridgeBio Pharma, Inc. has a high price of $74.95 with a market cap of $14.6 billion, but it faces significant challenges with a net profit margin of -60.3% and a price-to-sales ratio of 15.4

Insights · Forecast · Financials · Learn

Stocklytics home · Screener